Abstract
The key pathological features of chronic pancreatitis are chronic inflammation, acinar atrophy, and pancreatic fibrosis. We have previously shown that ellagic acid, a plant-derived polyphenol found in fruits and nuts, inhibited activation of pancreatic stellate cells, a major profibrogenic cell type in the pancreas, in vitro. Here we examined whether ellagic acid inhibited the development of pancreatic fibrosis in vivo. Ellagic acid was administered orally in the diet to ten-week-old male Wistar Bonn/Kobori rats, an experimental model of spontaneous chronic pancreatitis, for ten weeks. Ellagic acid (100 mg/kg body weight/day) attenuated pancreatic inflammation and fibrosis. The protective effects were confirmed by an increase in pancreatic weight and decreases in myeloperoxidase activity (an index of neutrophil infiltration), collagen content, transforming growth factor-β1 expression, and the number of α-smooth muscle actin-positive cells (activated pancreatic stellate cells) and ED-1-positive cells (macrophages/monocytes). Ellagic acid inhibited the production of reactive oxygen species in pancreatic stellate cells in response to transforming growth factor-β1 or platelet-derived growth factor. Our results suggest that ellagic acid might be a candidate for treatment of chronic pancreatitis.
Similar content being viewed by others
Abbreviations
- CP:
-
Chronic pancreatitis
- DCF-DA:
-
2′,7′-Dichlorofluorescein diacetate
- MPO:
-
Myeloperoxidase
- PCR:
-
Polymerase chain reaction
- PDGF:
-
Platelet-derived growth factor
- PSC:
-
Pancreatic stellate cell
- ROS:
-
Reactive oxygen species
- SMA:
-
Smooth muscle actin
- TGF:
-
Transforming growth factor
- WBN/Kob:
-
Wistar Bonn/Kobori
References
Steer ML, Waxman I, Freedman S (1995) Chronic pancreatitis. N Engl J Med 332:1482–1490. doi:10.1056/NEJM199506013322206
Ammann RW (2001) The natural history of alcoholic chronic pancreatitis. Intern Med 40:368–375. doi:10.2169/internalmedicine.40.368
Talukdar R, Saikia N, Singal DK, Tandon R (2006) Chronic pancreatitis: evolving paradigms. Pancreatology 6:440–9. doi:10.1159/000094561
Talukdar R, Tandon R (2008) Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. J Gastroenterol Hepatol 23:34–41
Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA et al (1998) Periacinar stellate-shaped cells in rat pancreas: identification, isolation and culture. Gut 43:128–133
Bachem MG, Schneider E, Gross H, Weidenbach H, Schmidt RM, Menke A et al (1998) Identification, culture, and characterization of pancreas stellate cells in rats and humans. Gastroenterology 115:421–432. doi:10.1016/S0016-5085(98)70209-4
Masamune A, Kikuta K, Satoh M, Sakai Y, Satoh A, Shimosegawa T (2002) Ligands of peroxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells. J Biol Chem. 277:141–147. doi:10.1074/jbc.M107582200
Pinzani M (2006) Pancreatic stellate cells: new kids become mature. Gut 55:12–14. doi:10.1136/gut.2005.074427
Omary MB, Lugea A, Lowe AW, Pandol SJ (2007) The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 117:50–59. doi:10.1172/JCI30082
Shimizu K, Shiratori K, Hayashi N, Kobayashi M, Fujiwara T, Horikoshi H (2002) Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis. Pancreas 24:184–190. doi:10.1097/00006676-200203000-00010
Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S et al (2003) Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 124:1010–1019. doi:10.1053/gast.2003.50147
Masamune A, Watanabe T, Kikuta K, Satoh K, Shimosegawa T (2008) NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 294:G99–G108. doi:10.1152/ajpgi.00272.2007
Meng M, Li YQ, Yan MX, Kou Y, Ren HB (2007) Effects of epigallocatechin gallate on diethyldithiocarbamate-induced pancreatic fibrosis in rats. Biol Pharm Bull 30:1091–1096. doi:10.1248/bpb.30.1091
Priyadarsini KI, Khopde SM, Kumar SS, Mohan H (2002) Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 50:2200–2206. doi:10.1021/jf011275g
Iino T, Tashima K, Umeda M, Ogawa Y, Takeeda M, Takata K et al (2002) Effect of ellagic acid on gastric damage induced in ischemic rat stomachs following ammonia or reperfusion. Life Sci 70:1139–1150. doi:10.1016/S0024-3205(01)01493-X
Thresiamma KC, Kuttan R (1996) Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol 40:363–366
Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW (1999) p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136:215–221. doi:10.1016/S0304-3835(98)00323-1
Khanduja KL, Gandhi RK, Pathania V, Syal N (1999) Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 37:313–318. doi:10.1016/S0278-6915(99)00021-6
Masamune A, Satoh M, Kikuta K, Suzuki N, Satoh K, Shimosegawa T (2005) Ellagic acid blocks activation of pancreatic stellate cells. Biochem Pharmacol 70:869–878. doi:10.1016/j.bcp. 2005.06.008
Ohashi K, Kim JH, Hara H, Aso R, Akimoto T, Nakama K (1990) WBN/Kob rats. A new spontaneously occurring model of chronic pancreatitis. Int J Pancreatol 6:231–247
Tasaki M, Umemura T, Maeda M, Ishii Y, Okamura T, Inoue T et al (2008) Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats. Food Chem Toxicol 46:1119–1124
Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, Shirai T (1995) Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett 94:113–121. doi:10.1016/0304-3835(95)03833-I
Sakthivel M, Elanchezhian R, Ramesh E, Isai M, Jesudasan CN, Thomas PA, Geraldine P (2008) Prevention of selenite-induced cataractogenesis in Wistar rats by the polyphenol, ellagic acid. Exp Eye Res 86:251–259
Ogawa Y, Kanatsu K, Iino T, Kato S, Jeong YI, Shibata N et al (2002) Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats. Life Sci 71:827–839. doi:10.1016/S0024-3205(02)01737-X
Dolber PC, Spach MS (1993) Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 41:465–469
Yamanaka K, Saluja AK, Brown GE, Yamaguch Y, Hofbauer B, Steer ML (1997) Protective effects of prostaglandin E1 on acute lung injury of caerulein-induced acute pancreatitis in rats. Am J Physiol 272:G23–G30
Masamune A, Kikuta K, Satoh M, Kume K, Shimosegawa T (2003) Differential roles of signaling pathways for proliferation and migration of rat pancreatic stellate cells. Tohoku J Exp Med. 199:69–84. doi:10.1620/tjem.199.69
Bimmler D, Schiesser M, Perren A, Scheele G, Angst E, Meili S et al (2004) Coordinate regulation of PSP/reg and PAP isoforms as a family of secretory stress proteins in an animal model of chronic pancreatitis. J Surg Res 118:122–135. doi:10.1016/S0022-4804(03)00342-1
Van Laethem JL, Deviere J, Resibois A, Deviere J (1996) Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 110:576–582. doi:10.1053/gast.1996.v110.pm8566606
Menke A, Yamaguchi H, Gress TM, Adler G (1997) Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat. Gastroenterology 113:295–303. doi:10.1016/S0016-5085(97)70107-0
Nagashio Y, Ueno H, Imamura M, Asaumi H, Watanabe S, Yamaguchi T et al (2004) Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Lab Invest 84:1610–1618. doi:10.1038/labinvest.3700191
Inoue M, Ino Y, Gibo J, Ito T, Hisano T, Arita Y et al (2002) The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 25:e64–e70. doi:10.1097/00006676-200211000-00023
Masamune A, Suzuki N, Kikuta K, Satoh K, Shimosegawa T (2006) Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 97:1080–1093. doi:10.1002/jcb.20698
Masamune A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T (2005) Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol 11:3368–3374
Asaumi H, Watanabe S, Taguchi M, Tashiro M, Nagashio Y, Nomiyama Y et al (2006) Green tea polyphenol (−)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells. Eur J Clin Invest 26:113–122. doi:10.1111/j.1365-2362.2006.01599.x
Scalbert A, Manach C, Morand C, Remesy C, Jimenez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287–306. doi:10.1080/1040869059096
Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN (2006) Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 113:189–207. doi:10.1016/j.jconrel.2006.04.015
Bala I, Bhardwaj V, Hariharan S, Sitterberg J, Bakowsky U, Kumar MNVR (2005) Design of biodegradable nanoparticles: a novel approach to encapsulating poorly soluble phytochemical ellagic acid. Nanotechnology 16:2819–2822. doi:10.1088/0957-4484/16/12/014
Kasai K, Yoshimura M, Koga T, Arii M, Kawasaki S (2006) Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. J Nutr Sci Vitaminol (Tokyo) 52:383–388. doi:10.3177/jnsv.52.383
Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G (2005) Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Eur Urol 47:449–455. doi:10.1016/j.eururo.2004.12.001
Acknowledgments
This work was supported in part by Grant-in-Aid from the Japan Society for the Promotion of Science (to A.M. and K.K.), by the Pancreas Research Foundation of Japan (to A.M. and K.K.), by the Kanae Foundation for Life and Socio-Medical Science (to A.M.), and by the Uehara Memorial Foundation (to A.M.).
Author information
Authors and Affiliations
Corresponding author
Additional information
N. Suzuki and K. Kikuta contributed equally to this work.
Rights and permissions
About this article
Cite this article
Suzuki, N., Masamune, A., Kikuta, K. et al. Ellagic Acid Inhibits Pancreatic Fibrosis in Male Wistar Bonn/Kobori Rats. Dig Dis Sci 54, 802–810 (2009). https://doi.org/10.1007/s10620-008-0423-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0423-7